Our previous work has shown that PERK mediates the cytotoxic signals of both the genotoxic and non-genotoxic chemotherapeutic drugs, including epirubicin and paclitaxel and has a role in modulating cancer drug resistance (Alasiri et al., 2019). The gene discussed is EIF2AK3; the disease is cancer.